Delays in Cancer Diagnostic Testing at a Quick Referral Unit in Spain during COVID-19

Although COVID-19 has had dire consequences on diagnosis of cancer, little data assessing its impact on the whole range of diagnostic activity relevant to cancer are available. We examined trends in the provision of full diagnostic tests for consecutive patients with suspected cancer referred to an...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Xavier Bosch, Manuel Torres, Pedro Moreno, Alfonso López-Soto
Formato:	article
Lenguaje:	EN
Publicado:	MDPI AG 2021
Materias:	COVID-19 cancer diagnosis quick diagnosis units suspected cancer primary care Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/4608b85465eb4438a52842a3db0af285
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:4608b85465eb4438a52842a3db0af285
record_format	dspace
spelling	oai:doaj.org-article:4608b85465eb4438a52842a3db0af2852021-11-25T17:21:34ZDelays in Cancer Diagnostic Testing at a Quick Referral Unit in Spain during COVID-1910.3390/diagnostics111120962075-4418https://doaj.org/article/4608b85465eb4438a52842a3db0af2852021-11-01T00:00:00Zhttps://www.mdpi.com/2075-4418/11/11/2096https://doaj.org/toc/2075-4418Although COVID-19 has had dire consequences on diagnosis of cancer, little data assessing its impact on the whole range of diagnostic activity relevant to cancer are available. We examined trends in the provision of full diagnostic tests for consecutive patients with suspected cancer referred to an academic hospital-based Quick Diagnosis Unit from January 2019 to December 2020. As weekly volumes declined, waiting times for endoscopic, imaging and biopsy/cytology procedures increased steeply during the COVID-impacted period (26 February–28 April 2020). The average weekly increase compared with the same period in 2019 was substantial for invasive procedures requiring admission (200.70%), CT scans (171.20%), GI endoscopy (161.50%), PET/CT scans (152.50%), ultrasonography (148.40%), and ambulatory biopsy/cytology procedures (111.20%). Volumes and waiting times to other procedures showed similar trends. There was a remarkable downward trend in cancer diagnosis during the COVID-impacted period, with a 54.07% reduction compared with the same weeks in 2019. Despite a modest recovery in the following months, the decline in weekly activity and cancer rates persisted until 30 December. Providing insight into how COVID-19 changed the full spectrum of diagnostic activity for suspected cancer informs resilience-building interventions to guarantee access to fast and efficient diagnostics ahead of new threats.Xavier BoschManuel TorresPedro MorenoAlfonso López-SotoMDPI AGarticleCOVID-19cancer diagnosisquick diagnosis unitssuspected cancerprimary careMedicine (General)R5-920ENDiagnostics, Vol 11, Iss 2096, p 2096 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	COVID-19 cancer diagnosis quick diagnosis units suspected cancer primary care Medicine (General) R5-920
spellingShingle	COVID-19 cancer diagnosis quick diagnosis units suspected cancer primary care Medicine (General) R5-920 Xavier Bosch Manuel Torres Pedro Moreno Alfonso López-Soto Delays in Cancer Diagnostic Testing at a Quick Referral Unit in Spain during COVID-19
description	Although COVID-19 has had dire consequences on diagnosis of cancer, little data assessing its impact on the whole range of diagnostic activity relevant to cancer are available. We examined trends in the provision of full diagnostic tests for consecutive patients with suspected cancer referred to an academic hospital-based Quick Diagnosis Unit from January 2019 to December 2020. As weekly volumes declined, waiting times for endoscopic, imaging and biopsy/cytology procedures increased steeply during the COVID-impacted period (26 February–28 April 2020). The average weekly increase compared with the same period in 2019 was substantial for invasive procedures requiring admission (200.70%), CT scans (171.20%), GI endoscopy (161.50%), PET/CT scans (152.50%), ultrasonography (148.40%), and ambulatory biopsy/cytology procedures (111.20%). Volumes and waiting times to other procedures showed similar trends. There was a remarkable downward trend in cancer diagnosis during the COVID-impacted period, with a 54.07% reduction compared with the same weeks in 2019. Despite a modest recovery in the following months, the decline in weekly activity and cancer rates persisted until 30 December. Providing insight into how COVID-19 changed the full spectrum of diagnostic activity for suspected cancer informs resilience-building interventions to guarantee access to fast and efficient diagnostics ahead of new threats.
format	article
author	Xavier Bosch Manuel Torres Pedro Moreno Alfonso López-Soto
author_facet	Xavier Bosch Manuel Torres Pedro Moreno Alfonso López-Soto
author_sort	Xavier Bosch
title	Delays in Cancer Diagnostic Testing at a Quick Referral Unit in Spain during COVID-19
title_short	Delays in Cancer Diagnostic Testing at a Quick Referral Unit in Spain during COVID-19
title_full	Delays in Cancer Diagnostic Testing at a Quick Referral Unit in Spain during COVID-19
title_fullStr	Delays in Cancer Diagnostic Testing at a Quick Referral Unit in Spain during COVID-19
title_full_unstemmed	Delays in Cancer Diagnostic Testing at a Quick Referral Unit in Spain during COVID-19
title_sort	delays in cancer diagnostic testing at a quick referral unit in spain during covid-19
publisher	MDPI AG
publishDate	2021
url	https://doaj.org/article/4608b85465eb4438a52842a3db0af285
work_keys_str_mv	AT xavierbosch delaysincancerdiagnostictestingataquickreferralunitinspainduringcovid19 AT manueltorres delaysincancerdiagnostictestingataquickreferralunitinspainduringcovid19 AT pedromoreno delaysincancerdiagnostictestingataquickreferralunitinspainduringcovid19 AT alfonsolopezsoto delaysincancerdiagnostictestingataquickreferralunitinspainduringcovid19
_version_	1718412467815579648

Delays in Cancer Diagnostic Testing at a Quick Referral Unit in Spain during COVID-19

Ejemplares similares